Back to search

Article

The effect of biologics on lung function improvements among severe eosinophilic asthma patients with partial reversibility or fixed obstructive defects: A retrospective analysis

2025-07-25

Abstract excerpt

<title>Abstract</title> <p>Background The management of SEA has evolved since the introduction of biologics in 2015, with clinical trials demonstrating reduced exacerbations and enhanced lung function. However, these trials typically exclude SEA patients without reversible airway obstruction on PFTs. This exclusion is significant, as many real-world SEA patients exhibit fixed or partially reversible obstruction,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fdb2fd36-dc49-538f-8091-a55de7a60e17
DOI
10.21203/rs.3.rs-6858802/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The effect of biologics on lung function improvements among severe eosinophilic asthma patients with partial reversibility or fixed obstructive defects: A retrospective analysisDOI 10.21203/rs.3.rs-6858802/v1
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic PhenotypeSemantic proximity
Mepolizumab for eosinophilic COPD with frequent exacerbations: single-centre real-world experience in a phenotype-directed approach.Semantic proximity
Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.Semantic proximity
Beyond the Inhaler: How Biologics, Phenotyping, and the Pursuit of Remission Are Redefining Airway Disease.Semantic proximity
Efficacy and safety of Depemokimab in asthma with eosinophilic phenotype: a systematic review and meta-analysis of randomized controlled trials.Semantic proximity
Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOS.Semantic proximity
Biologics in severe asthma: from precision phenotyping to clinical remission.Semantic proximity
The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.Semantic proximity
Monoclonal Antibodies in Idiopathic Chronic Eosinophilic Pneumonia: A Scoping ReviewSemantic proximity
Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotypeSemantic proximity
The efficacy of omalizumab treatment in patients with non-atopic severe asthmaSemantic proximity
Effectiveness of mepolizumab in a real-life cohort of patients with severe refractory eosinophilic asthma and multiple comorbiditiesSemantic proximity
Select a neighboring publication to make it the new centre.